Regulus Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $9,957,000.
Profit Margin
| 2014 | 7.66M | -56.68M | -739.08% |
|---|---|---|---|
| 2015 | 20.75M | -55.74M | -268.55% |
| 2016 | 1.19M | -81.83M | -6853.94% |
| 2017 | 72K | -71.90M | -99868.06% |
| 2018 | 72K | -48.70M | -67651.39% |
| 2019 | 6.83M | -18.59M | -272.13% |
| 2020 | 10.00M | -15.26M | -152.54% |
| 2021 | 0 | -27.80M | |
| 2022 | 0 | -28.32M | |
| 2023 | 0 | -30.03M |
RGLS Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 10.00M | 6.83M | 72K | 72K | 1.19M | 20.75M | 7.66M |
Cost of revenue | 21.15M | 122K | 459K | 15.34K | 12.34K | 0 | 54.59M | 0 | 56.38M | 41.04M |
Gross profit | -21.15M | -122K | -459K | 9.99M | 6.81M | 72K | -54.51M | 1.19M | -35.62M | -33.37M |
Operating exp. | ||||||||||
Research and development | 21.15M | 18.41M | 17.79M | 15.34M | 12.34M | 33.97M | 53.19M | 64.30M | 56.38M | 41.04M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 9.95M | 28.23M | 27.81M | 24.16M | 23.66M | 46.83M | 70.20M | 82.69M | 75.51M | 52.57M |
Operating income | -31.10M | -28.23M | -27.81M | -14.15M | -16.83M | -46.76M | -70.13M | -81.50M | -54.75M | -44.91M |
Other income (expenses), net | 1.07M | -83K | 9K | -1.57M | -1.75M | -1.88M | -1.97M | -338K | -1.00M | -11.76M |
Income before tax | -30.03M | -28.32M | -27.80M | -15.73M | -18.59M | -48.64M | -72.10M | -81.84M | -55.76M | -56.67M |
Income tax expense | 1K | 1K | 1K | -467K | 1K | 62K | -197K | -4K | -18K | 1K |
Net income | -30.03M | -28.32M | -27.80M | -15.26M | -18.59M | -48.70M | -71.90M | -81.83M | -55.74M | -56.68M |
Earnings per share | ||||||||||
Basic EPS | -1.58 | -1.86 | -3.24 | -4.36 | -10.77 | -55.87 | -114.7 | -185.94 | -130.12 | -154.27 |
Diluted EPS | -1.58 | -1.86 | -3.24 | -4.36 | -10.77 | -55.87 | -114.7 | -185.94 | -130.12 | -154.27 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |